NNPA NEWSWIRE — The administration unveiled a proposed framework for agencies to exercise march-in rights on taxpayer-funded drugs and inventions. According to the White House, this framework highlights the role of pricing considerations in determining accessibility to the public, asserting that taxpayer-funded medications should be reasonably priced and readily available.
The post Biden-Harris Administration Takes Sweeping Actions to Lower Healthcare Costs first appeared on BlackPressUSA.
